Purpose: Placental corticotropin-releasing hormone receptor type 1 (CRHR1) expression is reduced in pregnancies with abnormal placental function such as preeclampsia (PE), and the levels and/or function of CRHR1 are genetically influenced. The aim of this study was to investigate the association between the c.33+8199C>T polymorphism in the CRHR1 gene and PE in a Korean population. Materials and Methods: Using a case-control design, the association between the CRHR1 polymorphism and the risk of PE was investigated in 203 individuals with PE and 211 normotensive controls. Genotypes were determined using a SNapShot kit and an ABI Prism 3100 Genetic analyzer. Results: Genotypes and allele frequencies for the CRHR1 polymorphism did not differ between PE and normotensive pregnancies. The variant T allele was more frequent than the ancestral C allele in both of the groups and was more frequent in the controls than in the cases. In risk analysis for PE, there was not an increased risk of preeclampsia in subjects who were concomitant homozygous rare allele genotypes (CC) (OR, 0.3; P=0.15) or heterozygous rare allele genotypes (TC) (OR, 0.8; P=0.29). There were no differences in the complications of PE such as severity or preterm delivery in patients with the CRHR1 polymorphism. Conclusion: Our findings indicate that the CRHR1 polymorphism was not associated with PE in the present Korean study group.
Introduction
Preeclampsia (PE), a leading cause of maternal and neonatal morbidity and mortality, is a multifactorial disease affecting about 5-10% of all pregnancies. It requires intense monitoring and clinical supervision 1) . 4 and Hyun Mee Ryu
tissue and arterial invasion of trophoblasts 2, 3) . Therefore, the process of implantation between invasive trophoblast cells and the maternal endometerium is imporatnt in the maintenance of normal pregnancy 4) . However, the molecular interactions at the feto-maternal interface during the time of adhesion and subsequent invasion are not completely understood.
The hypothalamic corticotropin-releasing hormone (CRH)
is produced in several organs of the female reproductive system, including the endometrial glands, decidualized stroma, and trophoblast [5] [6] [7] [8] [9] . CRH, locally produced in the female reproductive organs, promotes implantation and maintenance of early pregnancy 9) . Moreover, CRH plasma levels are higher in women who deliver preterm and are lower in women who deliver postterm, compared to those in women who deliver at term 10) . These differences are evident at as early as 10 weeks of gestation. It seems that the patterns of plasma CRH are associated with aberrant timing of delivery 10) . Moreover, CRH participates in the maintenance of vascular tone by activating a guanylate cyclase/nitric oxide pathway in the human placenta 11) . Therefore, CRH plays a major role in controlling the mechanisms for the maintenance of pregnancy. . These receptors share 70% identity at the amino acid level, but have different binding properties from those of the members of the CRH family.
The gene encoding the CRH receptor type 1 (CRHR1) is located on 17q12-q22 and is expressed in human endometrial and myometrial cells, indicating a local effect of uterine CRH 13, 14) . Especially, placental CRHR1 expression is reduced in pregnancies with abnormal placental function such as PE 15) , and the levels and/or function of CRHR1 are genetically in- . However, the impact of the CRHR1 gene polymorphism on the risk of PE has not been investigated.
The aim of this study was to evaluate the allele and genotype frequencies of the CRHR1 gene polymorphism in PE and normotensive pregnancies and to investigate whether there is an association between this polymorphism and PE.
Materials and Methods
Subjects
This study involved 414 pregnant third trimester women collection and/or 2+ on dipstick testing) after 20 weeks ≥ of gestation. For analysis of the differences in complications of PE, the PE group was divided into two subgroups: severe PE (n=133) and PE with preterm delivery (n=105). Severe PE was defined as preeclampsia with severe hypertension (DBP 110 mmHg) and/or severe proteinuria (urinary protein ≥ excretion 5 g per 24 hours and/or 3+ on dipstick testing). ≥ ≥ Preterm delivery was defined as the delivery of a neonate at fewer than 37 weeks of gestation.
DNA Extraction and Genotyping
Peripheral blood was collected from all participants into ethylenediaminetetraacetic acid tubes (Becton Dickinson, Franklin Lakes, USA). Immediately after the sampling, genomic DNA was extracted using a QIAamp DNA Blood Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer s '
recommendations and was stored at -80 until required for ℃ analysis.
The CRHR1 polymorphism was analyzed using a single base primer extension assay performed with the SNapShot kit (Applied Biosystems, Foster City, USA) and an ABI Prism 3100 Genetic analyzer, according to our previous method 19, 20) . The polymorphism in the intron region of CRHR1 is located 
Statistical analysis
Data are presented as the mean standard deviation (SD) ± or number (%). The differences in clinical characteristics between the two groups were analyzed using the χ 
Results
Polymorphism analysis of the CRHR1 gene was performed in all subjects. The clinical characteristics of the study population are presented in Table 1 . The maternal age and nulliparity were not different between the PE and control cases (P >0.05). However, the maximum systolic and diastolic blood pressures were significantly higher in PE than in the control cases (P<0.001). Proteinuria was detected only in cases of . Furthermore, it acts as a marker for determining the length of gestation and the timing of parturition and delivery 10, 11) . Current theory suggests three roles of CRH in parturition; 1) CRH is associated with an increased level of dehydroepiandrosterone (DHEA), which has a role in preparing and stimulating cervical contractions; 2) CRH produces an increase in prostaglandin availability in uteroplacental tissues, and prostaglandins activate cervical contractions; and 3) prior to parturition, CRH may have a role in the inhibition of cervical contractions by increasing cAMP levels in the myometrium. Therefore, CRH is known as a potent vasodilator of the human fetoplacental circulation and may act as a local regulator of placental vascular tone.
The CRHRs, necessary factors for CRH action, are Gprotein-coupled receptors. It induces local effect of CRH in endometrial and myometrial cells in the uterine 13, 14) . Kateris et al. reported that significant reductions in the expression of CRHR1 mRNA and in its protein levels had been detected in preeclamptic placentas 15) . They suggested that the dampening of CRH-induced vasodilation could be attributable to the loss of CRHRs in placentas from preeclamptic pregnancies 15) . However, the association between CRHR polymorphism and PE has not yet been confirmed in Korean.
In this study, we analyzed, for the first time, the distribution and interaction of the CRHR1 polymorphism in Korean patients with preeclampsia. We found that the c.33+8199C>T polymorphism of CRHR1 gene was not associated with the risk of PE. Moreover, the homozygous genotype with the ancestral C allele showed the lowest frequencies in both of the groups and was more frequent in the control cases than in the PE cases.
However, these findings were not statistically significant. This study indicates that the c.33+8199C>T polymorphism of CRHR1 gene is not associated with PE in a Korean population. Therefore, we suggest that c.33+8199C>T polymorphism of the CRHR1 gene is not associated with susceptibility to the development of preeclampsia in pregnant Korean women. However, we only included Korean patients in this study and had a relatively small sample size. Our results therefore need to be confirmed in further studies involving a larger cohort of patients from other ethnic groups.
